

Faron Pharmaceuticals Buys Rights For AOC3 Antagonist Platform


(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals has acquired rights for the potential new use of AOC3 inhibitors cov...


Faron Pharmaceuticals Alters Traumakine Study After US FDA Feedback


Faron Pharma To Test Clevegen In Patients With Ovarian Cancer


Faron Pharma Gets Approval For Part II Trial Of Clevegen Drug


(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Monday that, further to the update on 'Traumakine' drug...


Faron Pharma Files For Arbitration Amid Traumakine Deal Termination


(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced new data from 'MATINS'-trial patients on Wednesday, to be ...